<DOC>
	<DOCNO>NCT02770248</DOCNO>
	<brief_summary>The purpose study evaluate difference treatment mean change baseline 24-hr IOP Week 4 .</brief_summary>
	<brief_title>24-hr Intraocular Pressure Control With SIMBRINZA ®</brief_title>
	<detailed_description>Subjects undergo washout pre-study IOP-lowering medication appropriate duration , undergo 2 eligibility visit . Eligible subject randomize 1:1 , receive mask SIMBRINZA ® Vehicle 4 week . Two 24-hour visit conduct ( Day 0 Week 4 ) intraocular pressure collect every 2 hour . The expected duration subject participation study 10 week .</detailed_description>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<criteria>Diagnosis either openangle glaucoma ocular hypertension ; Able attend study relate visit house overnight clinical site study assessment ; Willing able sign inform consent form ; Other protocolspecified inclusion criterion may apply . Women childbearing potential pregnant , intend become pregnant study , breastfeeding , use adequate birth control ; Diagnosed form glaucoma open angle glaucoma ocular hypertension ; Ocular surgery procedure exclude protocol ; Diseases , illnesses , infection , ocular abnormality exclude protocol ; Bestcorrected visual acuity score le 55 ETDRS letter ( equivalent approximately 20/80 Snellen ) either eye ; Other protocolspecific exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>